Company / Financials
Thermo Fisher Scientific Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$44.6B
FY2025 · +3.9% YoY
Net Income
$6.7B
FY2025 · +5.8% YoY
Profit Margin
15.0%
FY2025 · net income / revenue
ROE
12.6%
FY2025 · return on equity
Total Assets
$110.3B
FY2025
Total Debt
$39.2B
0.73x debt/equity
Equity
$53.4B
FY2025
ROA
6.1%
FY2025 · return on assets
Statement paths
Metric history
Revenue HistoryTotal revenue from operations$44.6B+3.9% YoYNet Income HistoryProfit after all expenses and taxes$6.7B+5.8% YoYGross Profit HistoryRevenue minus cost of goods sold$2.6BCost of Revenue HistoryDirect costs of producing goods and services sold$9.0BOperating Income HistoryProfit from core business operations before interest and taxes$7.7B+5.6% YoYSG&A Expense HistorySelling, general, and administrative expenses$8.7B+1.6% YoYR&D Expense HistoryResearch and development spending$1.4B+0.5% YoYInterest Expense HistoryCost of borrowing and debt obligations$536.0MIncome Tax HistoryTotal income tax expense$547.0M-16.7% YoYEPS (Basic) HistoryBasic earnings per share$15.52-12.6% YoY